Introduction
The design and synthesis of novel mono-, di-, and polycyclic fused nitrogen heterocyclic compounds is among the active principles in chemical materials, particularly those displaying strategic roles in the development of different industries, especially from the biological point of view. Pyrazoles and related fused heterocyclic derivatives have great importance in the medicinal field as biological agents such as antimicrobial, anti-inflammatory, and anticancer agents [1] [2] [3] [4] [5] [6] . The importance of pyrazole and pyrazolopyrimidine in the pharmacological industry as antitumor agents [7, 8] promoted us to synthesize new derivatives that may serve as new chemotherapeutic drugs.
A literature survey revealed that some drugs bearing pyrazole and pyrazolopyrimidine moieties are considered as the most active in drug manufacture such as Celecoxib [9] , Pyrazofurin [10] , Ramifenazone [11] , Zaleplon [12] , and Indiplon [13] , respectively [ Fig. 1 ].
In light of these facts and as a continuation of our previous work in the synthesis of novel compounds with promising biological applications [14] [15] [16] , we report herein the synthesis of new 5-aminopyrazole and pyrazolo [1,5-a] pyrimidine derivatives and an examination of their cytotoxic activity. The structures of the synthesized compounds were established based on elemental analysis and spectral data (IR, MS, 
Results and Discussion
Chemistry N-substituted cyanoacetamide derivatives 1a-c [17] were utilized as key starting materials in the synthesis of novel heterocyclic compounds (Schemes 1, 3, and 4). Cyanoacetamide derivatives 1a-c were reacted with 4-methoxyphenylisothiocyanate in absolute ethanol in the presence of an equimolar amount of potassium hydroxide to give the corresponding intermediates (2a-c); when the latter was alkylated with methyl iodide in ethanol, it afforded the novel ketene N,S-acetals 3a-c. band at 3314 corresponding to two NH groups and a band at 1664 for a C=O group. Its 1 H-NMR spectrum displayed three singlets at 2.55, 2.62, and 3.70 due to two -CH 3 and -OCH 3 protons, respectively, a signal at 6.92 corresponding to the H-6 proton of the pyrimidine nucleus, two doublets at 6.88 and 7.36 related to the four aromatic protons (AB system, J HH =7.8 Hz), another two doublets at 7.61 and 7.68 corresponding to the four aromatic protons in the other ring (AB system, J HH =6.7 Hz), and two singlets at 9.06 and 10.03 assignable to the two NH groups which were D 2 O exchangeable. Its ) showed an absorption band at 3447, 3296 which corresponds to the NH and NH 2 groups, a band at 2211 due to C≡N, and a band at 1653 due to C=O 
Biological Evaluation
In Vitro Cytotoxic Screening
In the present study, some of the newly synthesized compounds were evaluated in vitro for their cytotoxic activities against the Ehrlich Ascites Carcinoma cells (EAC) where Doxorubicin was used as a standard drug. The results were expressed as the IC 50 value, which corresponds to the concentration required for 50% inhibition of cell growth of the treated cells when compared to that of the control cells. From the results in Table 1 , it was found that compounds 7a (IC 50 =10 µg/ml) and 10c (IC 50 =25 µg/ml) exhibited the highest cytotoxic activity compared to the reference drug, Doxorubicin (IC 50 =37.4 µg/ml). The compounds 4b (IC 50 =50 µg/ml), 7b (IC 50 =47µg/ml), and 7c (IC 50 =42 µg/ml) displayed moderate cytotoxic activity against EAC cells, while compounds 4a, 4c, and 10b showed lower activity than the reference drug.
Tab. 1. Cytotoxicity of the tested compounds against Ehrlich Ascites Carcinoma (EAC) cells
Cpd. 
Non-viable cells (%)

Experimental
All melting points were measured on a Gallenkamp melting point apparatus and are uncorrected. The IR spectra were recorded (KBr disk) on a Perkin Elmer 1650 FTIR instrument. The 1 H-NMR (500 MHz) and 13 C-NMR (125 MHz) spectra were recorded on a Varian spectrometer using DMSO-d 6 or CDCl 3 as the solvent and TMS as an internal standard. Chemical shifts are reported in ppm. Mass spectra were recorded on a Varian MAT 112 spectrometer at 70 eV. Elemental analyses were performed at the Microanalytical Center, Cairo University, Egypt.
The progress of the reactions was monitored by thin-layer chromatography (TLC) using aluminum sheets coated with silica gel F 254 (Merck) with viewing under short-wavelength UV lamp detection. All evaporations were carried out under reduced pressure at 40 o C.
Reagents and solvents used in the synthesis were purchased from Sigma-Aldrich. Compounds 1a-c were prepared according to the reported procedure [17] .
N-(Aryl)-2-cyano-3-[(4-methoxyphenyl)amino]-3-(methylthio)acrylamides (3a-c)
A mixture of N-substituted cyanoacetamide derivatives 1a-c (0.01 mol) and 4-methoxyphenylisothiocyanate (0.01 mol) was heated for 5-10 min in ethanol (25 ml) containing potassium hydroxide (0.01 mol). After cooling, methyl iodide (0.01 mol) was added. The reaction mixture was stirred at room temperature for 1 h and then poured onto ice water. The precipitated product was filtered and recrystallized from ethanol.
2-Cyano-3-[(4-methoxyphenyl)amino]-3-(methylthio)-N-phenylacrylamide (3a)
Light yellow prisms, m.p. 102-104°C, yield (71% 
2-Cyano-3-[(4-methoxyphenyl)amino]-N-(4-methylphenyl)-3-(methylthio)acrylamide (3b)
Colorless prisms
N-(4-Chlorophenyl)-2-cyano-3-[(4-methoxyphenyl)amino]-3-(methylthio)acrylamide (3c)
5-Amino-N-aryl-3-[(4-methoxyphenyl)amino]-1H-pyrazole-4-carboxamides (4a-c)
A mixture of compounds 3a-c (0.01 mol), hydrazine hydrate (0.01 mol), and few drops of triethylamine in ethanol (30 ml) was refluxed for 4 h and then the solvent evaporated under reduced pressure. The resulting solid product was collected by filtration and recrystallized from ethanol. Amino-N-(4-chlorophenyl)-3-[(4-methoxyphenyl) 
5-Amino-3-[(4-methoxyphenyl)amino]-N-phenyl-1H-pyrazole-4-carboxamide (4a)
5-Amino-3-[(4-methoxyphenyl)amino]-N-(4-methylphenyl)-1H-pyrazole-4-carboxamide (4b)
5-
Synthesis of N-Aryl-2-[(4-methoxyphenyl)amino]-5,7-dimethylpyrazolo[1,5-a]-pyrimidine-3-carboxamide (7a-c)
A mixture of compounds 4a-c (0.01 mol) with acetylacetone 5 (0.01 mol) in glacial acetic acid (20 ml) was refluxed for 6 h, then poured onto crushed ice, and the separated solid was filtered, dried well, and recrystallized from ethanol to afford compounds 7a-c.
2-[(4-Methoxyphenyl)amino]-5,7-dimethyl-N-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide (7a)
White crystals, m.p. 215-217°C, yield (85%). IR (KBr) ν max /cm −1 3305 (NH), 1653 (C=O). [1,5-a] [1,5-a] -N-aryl-6-cyano-5-(4-methoxyphenyl)-2-[(4-methoxyphenyl)-amino]pyrazolo[1,5-a]pyrimidine-3-carboxamides (10a-c) A mixture of compounds 4a-c (0.01 mol) with 2-(4-methoxybenzylidene)malononitrile 8 (0.01 mol) and a catalytic amount of triethylamine (four drops) in absolute ethanol (30 ml) was refluxed for 6 h. The solvent was concentrated under reduced pressure and the solid obtained was collected and recrystallized from ethanol to give 10a-c. [1,5-a] [1,5-a] 
2-[(4-Methoxyphenyl)amino]-5,7-dimethyl-N-(4-methylphenyl)pyrazolo
N-(4-Chlorophenyl)-2-[(4-methoxyphenyl)amino]-5,7-dimethylpyrazolo
Synthesis of 7-amino
7-Amino-6-cyano-5-(4-methoxyphenyl)-2-[(4-methoxyphenyl)amino]-N-phenylpyrazolo
7-Amino-N-(4-chlorophenyl)-6-cyano-5-(4-methoxyphenyl)-2-[(4-methoxyphenyl)amino]-pyrazolo
Biological Experiments
In Vitro Cytotoxic Activity Doxoroubicin, the reference drug which was used in this study, is one of the most effective antitumor agents used to produce regressions in acute leukemia, Hodgkin disease, and other lymphoma. The relationship between the survival ratio and drug concentration was plotted to obtain the survival curve of the Ehrlich Ascites Carcinoma (EAC) cells. The parameter IC 50 is the concentration of the drugs inducing 50% inhibition of cell growth of the treated cells in comparison with the growth of the control cells.
Procedure
The EAC cells were obtained by needle aspiration of the ascetic from preinoculated mice under aseptic conditions. The tumor cells suspension (2.5×10 6 cells/ml) was prepared in RPMI-1640 media. The tested compounds were prepared with various dilutions by dissolving: 100, 50, 25, and 10 µg in DMSO (1 ml). In a set of sterile test tubes, to 0.8 ml of RPMI-1640 media containing (glutamine, fetal calf serum as the nutrient, streptomycin, and pencillin) 0.1 ml of each tested compound was added. The test tube was then incubated at 37°C for 2 h. 
Conclusion
In conclusion, N-substituted cyanoacetamide derivatives 1a-c were used as starting materials for the synthesis of some new N-(aryl)-2-cyano-3-(methylthio)acrylamides 3a-c, 5-amino-1H-pyrazoles 4a-c, and pyrazolo[1,5-a]pyrimidines 7a-c and 10a-c. The new synthesized compounds were characterized by analytical and spectroscopic data. Some selected new compounds were screened for their potential cytotoxic activity. The results of the cytotoxicity for the tested compounds against Ehrlich Ascites Carcinoma (EAC) cells indicated that the pyrazolo[1,5-a]pyrimidine derivatives 7a (IC 50 =10 µg/ml) and 10c (IC 50 =25 µg/ml) were found to have the most potent growth inhibitory activity against EAC cells in comparison with the reference drug, Doxorubicin (IC 50 =37.4 µg/ml). Accordingly, this class of compounds could be considered as useful templates for future development, derivatization, or modification to obtain more potent and selective antitumor agents.
